These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2474101)

  • 41. [Influence of acute administration of ramipril on the excretion of uric acid].
    Labeeuw M; Pozet N; Zech PY; Hadj-Aissa A; Finaz de Villaine J; Laville M
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):870-4. PubMed ID: 2959232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension.
    Karlberg BE; Lindström T; Rosenqvist U; Ohman KP
    Am J Cardiol; 1987 Apr; 59(10):104D-109D. PubMed ID: 3034016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
    Bender N; Rangoonwala B; Rosenthal J; Vasmant D
    Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of angiotensin-converting enzyme inhibition on human tissue renin.
    Rosenthal J; Buehler G; Koenig W; Rangoonwala B
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S122-4. PubMed ID: 1725019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium.
    Keilani T; Danesh FR; Schlueter WA; Molteni A; Batlle D
    Am J Kidney Dis; 1999 Mar; 33(3):450-7. PubMed ID: 10070908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans.
    Higashi Y; Oshima T; Ono N; Hiraga H; Yoshimura M; Watanabe M; Matsuura H; Kambe M; Kajiyama G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2198-202. PubMed ID: 7608279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of natriuresis by sympathetic nerves and angiotensin II in conscious dogs.
    Persson PB; Ehmke H; Kögler U; Kirchheim H
    Am J Physiol; 1989 Mar; 256(3 Pt 2):F485-9. PubMed ID: 2522278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
    Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
    Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Salt blocks the renal benefits of ramipril in diabetic hypertensive rats.
    Fabris B; Jackson B; Johnston CI
    Hypertension; 1991 Apr; 17(4):497-503. PubMed ID: 1826492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of ramipril on arterial hemodynamics.
    Benetos A; Vasmant D; Thiéry P; Safar M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S153-6. PubMed ID: 1725030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
    Quaschning T; Hocher B; Ruhl S; Kraemer-Guth A; Tilgner J; Wanner C; Galle J
    Kidney Blood Press Res; 2006; 29(6):351-9. PubMed ID: 17139187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
    Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
    Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.
    Todd PA; Benfield P
    Drugs; 1990 Jan; 39(1):110-35. PubMed ID: 2138076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of ramipril, a new angiotensin-converting enzyme inhibitor on cortical nephron flow and effective renal plasma flow in patients with essential hypertension.
    al-Nahhas AM; Nimmon CC; Britton KE; Carroll MJ; al-Janabi MA; Solanki K; Bomanji J
    Nephron; 1990; 54(1):47-52. PubMed ID: 2136939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
    Brown NJ; Abbas A; Byrne D; Schoenhard JA; Vaughan DE
    Circulation; 2002 Jan; 105(3):304-9. PubMed ID: 11804984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.